Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal osteoporosis.

N B Watts1

  • 1Osteoporosis and Bone Health Program, Emory Clinic, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Obstetrical & Gynecological Survey
|August 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of spaceflight countermeasures on trabecular bone score (TBS) of the lumbar spine.

Archives of osteoporosis·2026
Same author

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Correction to: Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Factors associated with the contemplative stage of readiness to initiate osteoporosis treatment.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Abaloparatide effect on forearm bone mineral density and wrist fracture risk in postmenopausal women with osteoporosis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2019
Same journal

Amniotic Fluid Embolism: A Silent Threat to Maternal Life- An Up-to-Date Comprehensive Review of the Pathophysiology, Diagnosis, and Outcome.

Obstetrical & gynecological survey·2026
Same journal

A System Review of Pathophysiology, Diagnosis, and Clinical Management of Intrauterine Adhesions.

Obstetrical & gynecological survey·2026
Same journal

Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management.

Obstetrical & gynecological survey·2026
Same journal

Heavy Menstrual Bleeding in the Gynecology Clinic: A Call for Awareness and Standardized Screening for Underlying Bleeding Disorders.

Obstetrical & gynecological survey·2026
Same journal

Uterine Sarcomas: Clinical Management and a Review of Systemic Therapy.

Obstetrical & gynecological survey·2026
Same journal

Female Sexual Dysfunction: Current Models and Treatment Options.

Obstetrical & gynecological survey·2026
See all related articles

Osteoporosis impacts millions, with low bone density being a key risk factor. Early screening and lifestyle changes, alongside medications like alendronate, are vital for managing osteoporosis in women.

Area of Science:

  • Bone health and osteoporosis management.
  • Pharmacological and lifestyle interventions for osteoporosis.

Background:

  • Osteoporosis affects 28 million Americans, costing $14 billion annually.
  • Low bone density is the primary risk factor for osteoporosis.
  • National Osteoporosis Foundation guidelines recommend bone density testing for women over 65 and earlier for those with risk factors.

Purpose of the Study:

  • To understand the clinical impact and sequelae of osteoporosis in women.
  • To identify high-risk patients and those requiring screening.
  • To review available screening, monitoring tests, and pharmacologic therapies for osteoporosis.

Main Methods:

  • Review of current recommendations for osteoporosis screening and diagnosis.
  • Evaluation of lifestyle modifications including calcium, vitamin D, and weight-bearing exercise.

Related Experiment Videos

  • Analysis of pharmacologic agents for osteoporosis prevention and treatment.

    • Main Results:

    • Bone density testing is recommended for specific populations of women.
    • Biochemical markers can aid in treatment decisions and monitoring effectiveness.
    • Pharmacologic agents are indicated for fragility fractures and low bone density, with alternatives to estrogen therapy available.

    Conclusions:

    • Lifestyle interventions are crucial for all individuals.
    • Pharmacologic agents like alendronate and raloxifene are effective alternatives for prevention and treatment.
    • Nasal calcitonin is also an effective treatment for established osteoporosis.